MNK

Mallinckrodt (MNK)

Mallinckrodt plc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:MNK

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/29	20 : 22	IH Market News	Tuesday’s Wall Street Highlights: Alphabet, Verizon, Joann, Intel, Catalent, and more	AMEX:MNK	Mallinckrodt plc
2023/08/28	17 : 46	PR Newswire (US)	Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations	AMEX:MNK	Mallinckrodt plc
2023/08/28	13 : 17	PR Newswire (US)	Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations	AMEX:MNK	Mallinckrodt plc
2023/08/23	21 : 32	PR Newswire (US)	Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan	AMEX:MNK	Mallinckrodt plc
2023/08/23	21 : 22	PR Newswire (US)	Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan	AMEX:MNK	Mallinckrodt plc
2023/08/09	19 : 45	PR Newswire (US)	Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance	AMEX:MNK	Mallinckrodt plc
2023/06/15	19 : 52	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023	AMEX:MNK	Mallinckrodt plc
2023/06/13	15 : 30	PR Newswire (US)	Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients	AMEX:MNK	Mallinckrodt plc
2023/06/01	19 : 52	PR Newswire (US)	Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023	AMEX:MNK	Mallinckrodt plc
2023/05/09	19 : 45	PR Newswire (US)	Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance	AMEX:MNK	Mallinckrodt plc
2023/05/08	19 : 52	PR Newswire (US)	Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023	AMEX:MNK	Mallinckrodt plc
2023/05/05	19 : 52	PR Newswire (US)	Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards	AMEX:MNK	Mallinckrodt plc
2023/04/28	21 : 00	Business Wire	Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment Scheme	AMEX:MNK	Mallinckrodt plc
2023/04/24	19 : 45	PR Newswire (US)	Mallinckrodt to Report Earnings Results for First Quarter 2023	AMEX:MNK	Mallinckrodt plc
2023/04/10	19 : 53	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)	AMEX:MNK	Mallinckrodt plc
2023/03/21	19 : 53	PR Newswire (US)	Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual Meeting	AMEX:MNK	Mallinckrodt plc
2023/03/09	17 : 00	PR Newswire (US)	Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)	AMEX:MNK	Mallinckrodt plc
2023/02/28	20 : 45	PR Newswire (US)	Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance	AMEX:MNK	Mallinckrodt plc
2023/02/16	22 : 03	PR Newswire (US)	Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference	AMEX:MNK	Mallinckrodt plc
2023/02/08	20 : 45	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Fourth Quarter 2022	AMEX:MNK	Mallinckrodt plc
2023/01/23	04 : 00	PR Newswire (US)	Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress	AMEX:MNK	Mallinckrodt plc
2022/11/16	20 : 52	PR Newswire (US)	Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award	AMEX:MNK	Mallinckrodt plc
2022/11/08	20 : 45	PR Newswire (US)	Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance	AMEX:MNK	Mallinckrodt plc
2022/11/01	19 : 53	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific Meeting	AMEX:MNK	Mallinckrodt plc